跳至主要内容
临床试验/NL-OMON44912
NL-OMON44912已完成不适用

Quantitative GLP-1 receptor imaging correlated to ex vivo distribution of In-111-exendin - GLP-1-ex-vivo

ucleaire Geneeskunde0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Scheduled for partial or complete pancreatectomy or complete drainage procedure in case of chronic pancreatitis, Intraductal papillary mucinous neoplasm (IPMN) or pancreatic cancer at Radboudumc

排除标准

  • * Resection of only small part of the pancreas without possibility to safely sample other pancreatic parts
  • * Breast feeding
  • * Pregnancy or the wish to become pregnant within 6 months
  • * Creatinine clearance below 40ml/min
  • * Liver disease defined as aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range
  • * Age < 18 years
  • previous treatment with synthetic Exendin (Exenatide, Byetta®) or Dipeptidyl-Peptidase IV inhibitors

研究者

发起方
ucleaire Geneeskunde

相似试验

Quantitative GLP-1 receptor imaging correlated to ex... | 临床试验